Impact of BMGIM Music Therapy on Emotional State in Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial

• Published in: Journal of clinical medicine Vol. 10; no. 8; p. 1591
• Main Authors: March-Luján, Vicente Alejandro, Prado-Gascó, Vicente, Huguet, José María, Cortés, Xavier, Arquiola, José María Paredes, Capilla-Igual, María, Josefa-Rodríguez-Morales, María, Monzó-Gallego, Ana, Armero, José Luis Platero, Ortí, José Enrique de la Rubia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.04.2021; MDPI
• Subjects: Adaptation; Anxiety; Chronic illnesses; Clinical trials; Hormones; Hospitals; Immunocompetence; Immunoglobulins; Inflammatory bowel disease; Informed consent; Intervention; Mental depression; Music therapy; Patients; Quality of life; Questionnaires; Remission (Medicine); Steroids; Stress; anxiety; depression; guided imagery; music therapy; emotional aspects; inflammatory bowel disease
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm10081591

Patients with inflammatory bowel disease (IBD) have a high prevalence of emotional disturbances which worsen the symptoms of the disease. As a therapeutic alternative that is part of a comprehensive care alongside medication, the Bonny Method of Guided Imagery and Music (BMGIM) music-assisted therapy has achieved promising emotional improvements in patients with chronic diseases. The objective of the study was to determine the impact of a treatment based on a BMGIM group adaptation on patients with inflammatory bowel disease (IBD) and their emotional state, therefore analyzing state of mind, quality of life, anxiety, depression, immunocompetence as a marker of well-being, and levels of acute and chronic stress. Longitudinal, prospective, quantitative, and experimental study including 43 patients with IBD divided into an intervention group (22 patients), who received eight sessions over eight weeks, and a control group (21 patients). A saliva sample was taken from each patient before and after each session in order to determine cortisol and IgA levels. Similarly, a hair sample was taken before the first and after the last session to determine the cumulative cortisol level. All molecules were quantified using the ELISA immunoassay technique. In addition, patients completed several emotional state questionnaires: HADS, MOOD, and CCVEII. An improvement was observed in the following states of mind: sadness, fear, anger, and depression. No significant effect was observed in state of mind in terms of happiness or anxiety, in the levels of cortisol in hair, and in patients' perceived quality of life. A reduction in cortisol was observed in saliva, although this did not significantly affect the IgA titer. BMGIM seems to improve the emotional state of patients with IBD.